216 related articles for article (PubMed ID: 9758890)
61. Inhibition of corneal allograft reaction by CTLA4-Ig.
Hoffmann F; Zhang EP; Pohl T; Kunzendorf U; Wachtlin J; Bulfone-Paus S
Graefes Arch Clin Exp Ophthalmol; 1997 Aug; 235(8):535-40. PubMed ID: 9285225
[TBL] [Abstract][Full Text] [Related]
62. CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma.
Serebrisky D; Teper AA; Huang CK; Lee SY; Zhang TF; Schofield BH; Kattan M; Sampson HA; Li XM
J Immunol; 2000 Nov; 165(10):5906-12. PubMed ID: 11067952
[TBL] [Abstract][Full Text] [Related]
63. CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection.
King CL; Xianli J; June CH; Abe R; Lee KP
Eur J Immunol; 1996 Oct; 26(10):2448-55. PubMed ID: 8898959
[TBL] [Abstract][Full Text] [Related]
64. Involvement of CD28/CTLA4-B7 costimulatory pathway in the development of lymphadenopathy and splenomegaly in MRL/lpr mice.
Takiguchi M; Murakami M; Nakagawa I; Rashid MM; Tosa N; Chikuma S; Hashimoto A; Uede T
J Vet Med Sci; 2000 Jan; 62(1):29-36. PubMed ID: 10676886
[TBL] [Abstract][Full Text] [Related]
65. Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis.
Perrin PJ; Scott D; Davis TA; Gray GS; Doggett MJ; Abe R; June CH; Racke MK
J Neuroimmunol; 1996 Mar; 65(1):31-9. PubMed ID: 8642061
[TBL] [Abstract][Full Text] [Related]
66. Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma.
Van Oosterhout AJ; Hofstra CL; Shields R; Chan B; Van Ark I; Jardieu PM; Nijkamp FP
Am J Respir Cell Mol Biol; 1997 Sep; 17(3):386-92. PubMed ID: 9308926
[TBL] [Abstract][Full Text] [Related]
67. Costimulatory signal through CD86 is important in Th2 response in Trichinella spiralis infected mice.
Wang Z; Takamoto M; Sugane K
Parasite Immunol; 2000 Mar; 22(3):121-30. PubMed ID: 10672193
[TBL] [Abstract][Full Text] [Related]
68. Identification of conserved amino acids in murine B7-1IgV domain critical for CTLA4/CD28:B7 interaction by site-directed mutagenesis: a novel structural model of the binding site.
Guo Y; Wu Y; Kong X; Liu Y
Mol Immunol; 1998 Mar; 35(4):215-25. PubMed ID: 9736337
[TBL] [Abstract][Full Text] [Related]
69. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma.
Padrid PA; Mathur M; Li X; Herrmann K; Qin Y; Cattamanchi A; Weinstock J; Elliott D; Sperling AI; Bluestone JA
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):453-62. PubMed ID: 9533932
[TBL] [Abstract][Full Text] [Related]
70. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite.
Lu P; Zhou X; Chen SJ; Moorman M; Morris SC; Finkelman FD; Linsley P; Urban JF; Gause WC
J Exp Med; 1994 Aug; 180(2):693-8. PubMed ID: 8046343
[TBL] [Abstract][Full Text] [Related]
71. Role of CD4(+) CD25(+) regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways.
Suto A; Nakajima H; Kagami SI; Suzuki K; Saito Y; Iwamoto I
Am J Respir Crit Care Med; 2001 Aug; 164(4):680-7. PubMed ID: 11520737
[TBL] [Abstract][Full Text] [Related]
72. Stimulatory effects of B7-related protein-1 on cellular and humoral immune responses in mice.
Guo J; Stolina M; Bready JV; Yin S; Horan T; Yoshinaga SK; Senaldi G
J Immunol; 2001 May; 166(9):5578-84. PubMed ID: 11313397
[TBL] [Abstract][Full Text] [Related]
73. Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2-dependent mechanism.
Blazevic V; Pinto LA; Trubey CM; Shearer GM
J Leukoc Biol; 2000 Jun; 67(6):817-24. PubMed ID: 10857854
[TBL] [Abstract][Full Text] [Related]
74. CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model.
Deurloo DT; van Esch BC; Hofstra CL; Nijkamp FP; van Oosterhout AJ
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):751-60. PubMed ID: 11726402
[TBL] [Abstract][Full Text] [Related]
75. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
Elloso MM; Scott P
J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289
[TBL] [Abstract][Full Text] [Related]
76. Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor.
Razi-Wolf Z; Galvin F; Gray G; Reiser H
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11182-6. PubMed ID: 7504299
[TBL] [Abstract][Full Text] [Related]
77. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines.
Walter H; Schepensn S; Van Wauwe J; de Boer M
Eur Cytokine Netw; 1994; 5(1):13-21. PubMed ID: 7519453
[TBL] [Abstract][Full Text] [Related]
78. Abatacept (Cytotoxic T Lymphocyte Antigen 4-Fragment Crystallizable) Reduces Allergic Inflammation of Ovalbumin-Sensitized Mice.
Chung J; Choi MR; Kim MG; Park SK; Kim YM
Am J Rhinol Allergy; 2022 Jul; 36(4):432-439. PubMed ID: 34994213
[TBL] [Abstract][Full Text] [Related]
79. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis.
Corry DB; Reiner SL; Linsley PS; Locksley RM
J Immunol; 1994 Nov; 153(9):4142-8. PubMed ID: 7523517
[TBL] [Abstract][Full Text] [Related]
80. CTLA4-Ig inhibits allergic airway inflammation by a novel CD28-independent, nitric oxide synthase-dependent mechanism.
Deppong CM; Parulekar A; Boomer JS; Bricker TL; Green JM
Eur J Immunol; 2010 Jul; 40(7):1985-94. PubMed ID: 20443189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
